Home Cart 0 Sign in  
X

[ CAS No. 4651-81-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4651-81-4
Chemical Structure| 4651-81-4
Chemical Structure| 4651-81-4
Structure of 4651-81-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4651-81-4 ]

Related Doc. of [ 4651-81-4 ]

Alternatived Products of [ 4651-81-4 ]

Product Details of [ 4651-81-4 ]

CAS No. :4651-81-4 MDL No. :MFCD00159547
Formula : C6H7NO2S Boiling Point : -
Linear Structure Formula :- InChI Key :DGGJQLCAYQCPDD-UHFFFAOYSA-N
M.W : 157.19 Pubchem ID :78381
Synonyms :

Calculated chemistry of [ 4651-81-4 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.0
TPSA : 80.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.79
Log Po/w (XLOGP3) : 1.66
Log Po/w (WLOGP) : 1.12
Log Po/w (MLOGP) : 0.29
Log Po/w (SILICOS-IT) : 1.65
Consensus Log Po/w : 1.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.1
Solubility : 1.25 mg/ml ; 0.00797 mol/l
Class : Soluble
Log S (Ali) : -2.97
Solubility : 0.17 mg/ml ; 0.00108 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.37
Solubility : 6.71 mg/ml ; 0.0427 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.19

Safety of [ 4651-81-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4651-81-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4651-81-4 ]
  • Downstream synthetic route of [ 4651-81-4 ]

[ 4651-81-4 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 4651-81-4 ]
  • [ 77287-34-4 ]
  • [ 14080-50-3 ]
YieldReaction ConditionsOperation in experiment
66% at 190℃; for 4 h; A solution of methyl 2-aminothiophene-3-carboxylate (3.0 g, 19.1 mmol) in formamide (95 ml) was heated at 190° C. for 4 hours. The cooled mixture was poured into water. The precipitate was filtered off, washed with water and dried. The crude product was purified by silica gel chromatography (CH2Cl2/MeOH 50:1) to yield the title compound as a white solid (1.93 g, 66percent).1H NMR (300 MHz, DMSO, 25° C.): δ=12.49 (s, 1H, NH), 8.13 (s, 1H, CH), 7.58 (d, J=5.8 Hz, 1H, CH), 7.39 (d, J=5.8 Hz, 1H, CH) ppm.HRMS: calcd for C6H5N2OS 153.01226, found 153.01155.
66% at 190℃; for 4 h; Example 304
Synthesis of thieno[2,3-d]pyrimidin-4(3H)-one
A solution of methyl 2-aminothiophene-3-carboxylate (3.0 g, 19.1 mmol) in formamide (95 ml) was heated at 190° C. for 4 hours.
The cooled mixture was poured into water.
The precipitate was filtered off, washed with water and dried.
The crude product was purified by silica gel chromatography (CH2Cl2/MeOH 50:1) to yield the title compound as a white solid (1.93 g, 66percent).
1H NMR (300 MHz, DMSO, 25° C.): δ=12.49 (s, 1H, NH), 8.13 (s, 1H, CH), 7.58 (d, J=5.8 Hz, 1H, CH), 7.39 (d, J=5.8 Hz, 1H, CH) ppm.
HRMS: calcd for C6H5N2OS 153.01226, found 153.01155.
66% at 190℃; for 4 h; Example 304
Synthesis of thieno[2,3-d]pyrimidin-4(3H)-one
A solution of methyl 2-aminothiophene-3-carboxylate (3.0 g, 19.1 mmol) in formamide (95 ml) was heated at 190° C. for 4 hours.
The cooled mixture was poured into water.
The precipitate was filtered off, washed with water and dried.
The crude product was purified by silica gel chromatography (CH2Cl2/MeOH 50:1) to yield the title compound as a white solid (1.93 g, 66percent).
1H NMR (300 MHz, DMSO, 25° C.): δ=12.49 (s, 1H, NH), 8.13 (s, 1H, CH), 7.58 (d, J=5.8 Hz, 1H, CH), 7.39 (d, J=5.8 Hz, 1H, CH) ppm.
HRMS: calcd for C6H5N2OS 153.01226. found 153.01155.
58% at 150℃; for 6 h; 2-aminothiophene-3-carboxylic acid methyl ester (4.7 g, 30 mmol) was added to a 250 mL round bottom flask.Ammonium formate (6.3g, 100mmol) and 25mL formamide,The mixture was heated at 150 °C with stirring for 6 h.After the reaction was completed, it was stored at 0°C for 24 hours and suction filtered to give a brown solid (2.8 g, 58percent).
50% at 215℃; for 5 h; The synthesis was carried out according to the procedure of Jang et al.35   Methyl 2-aminothiophene-3-carboxylate (1) (26.0 g, 165 mmol) was mixed with   formamide (285 mL) and heated at 215 °C for 5 h. The reaction mixture was then cooled to rt and   water (500 mL) was added, followed by extraction with EtOAc (4×500 mL). The combined organic fractions were dried over Na2SO4, and concentrated. Upon storage at −18 °C a solid material precipitated, which was washed with cold EtOAc (4×100 mL). This gave 12.7 g (83.0 mmol, 50percent) of   2 as a yellowish solid, mp. 245 °C (dec), (lit.22 245 °C, dec); 1H NMR (400 MHz, DMSO-d6) δ: 12.45 (s br, 1H), 8.12 (s, 1H), 7.57 (d, J=5.8, 1H), 7.39 (d, J=5.8, 1H); 13C NMR (100 MHz, DMSO-d6) δ: 164.2, 157.5, 145.6, 124.6, 123.8, 121.6; IR (neat, cm−1): 2879, 1647, 1577, 800, 701, 635; HRMS (EI, 70 eV, m/z): 152.0045 (calcd C6H4N2OS, 152.0044, M+). The NMR spectroscopic data corresponds with that reported previously.22
50% at 215℃; for 5 h; Thieno[2,3-d]pyrimidin-4(3H)-one (2). Methyl 2-aminothiophene-3-carboxylate (1) (26.0 g, 165 mmol) was mixed with formamide (285 mL) and heated at 215 °C for 5 h. The reaction mixture was then cooled to rt. and water (500 mL) was added, followed by extraction with EtOAc (4 x 500 mL). The combined organic fractions were dried over Na2S04, and concentrated. Upon storage at -18 °C a solid material precipitated which was washed with cold EtOAc (4 x 100 mL). This gave 12.7 g (83.0 mmol, 50percent) of 2 as a yellowish solid, mp. 245 °C (dec); 1H NMR (400 MHz, DMSO-d6) δ: 12.45 (s br, 1H), 8.12 (s, 1H), 7.57 (d, J= 5.8, 1H), 7.39 (d, J= 5.8, 1H); 13C NMR (100 MHz, DMSO-de) δ: 164.2, 157.5, 145.6, 124.6, 123.8, 121.6. IR (neat, cm"1): 2879, 1647, 1577, 800, 701, 635; HRMS (EI, 70 eV, m/z): 152.0045 (calcd C6H4N2OS, 152.0044, M+).
23% at 190℃; for 3 h; Methyl 2-aminothiophene-3- carboxylate (10 g, 64 mmol) was charged with formamide (50 mL). The reaction was heated at 190 °C under nitrogen for 3 hours, then cooled to ambient temperature. The resulting slurry was poured into 125 mL of water and extracted with chloroformdsopropyl alcohol mixture (2 times). The solution was concentrated and triturated to afford the title compound (2.25 g, 23percent).
3.45 g at 200℃; for 4 h; Inert atmosphere Under an argon atmosphere,118 mL of formamide was added to 7.83 g of methyl 2-aminothiophene-3-carboxylate,The mixture was stirred at 200 ° C. for 4 hours,The temperature was returned to room temperature.Water was added and the mixture was extracted 9 times with ethyl acetate,The organic layer was dried over anhydrous sodium sulfate,After filter paper filtering,The solvent was distilled off under reduced pressure. The solid obtained was subjected to decantation with ethyl acetate 8 times, washed and dried under reduced pressure to give 3.45 g of the title compound as a brown solid.

Reference: [1] Patent: US2012/46278, 2012, A1, . Location in patent: Page/Page column 81
[2] Patent: US2013/190297, 2013, A1, . Location in patent: Paragraph 1205; 1206; 1207
[3] Patent: US2014/88088, 2014, A1, . Location in patent: Paragraph 1220-1222
[4] Patent: CN107573386, 2018, A, . Location in patent: Paragraph 0048-0050
[5] Tetrahedron, 2012, vol. 68, # 45, p. 9226 - 9233
[6] Patent: WO2015/959, 2015, A1, . Location in patent: Page/Page column 47-48
[7] ChemMedChem, 2015, vol. 10, # 1, p. 69 - 82
[8] MedChemComm, 2015, vol. 6, # 2, p. 339 - 346
[9] Patent: WO2008/118718, 2008, A2, . Location in patent: Page/Page column 61
[10] Bulletin de la Societe Chimique de France, 1975, p. 587 - 591
[11] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 3, p. 844 - 847
[12] Patent: JP2018/154587, 2018, A, . Location in patent: Paragraph 0079
  • 2
  • [ 4651-81-4 ]
  • [ 3473-63-0 ]
  • [ 14080-50-3 ]
YieldReaction ConditionsOperation in experiment
77.7% at 80℃; for 24 h; 250 mL of a three-necked flask,A solution of methyl 2-aminothiophene-3-carboxylate (20 g, 0.127 mol) and formamidine acetate (30 g, 0.29) was dissolved in ethanol at 80 °C for 24 hours and the reaction was complete until the reaction was complete. After the reaction solution was cooled, the mixture was stirred in water,The precipitated solid was filtered and the cake was dried to obtain 15 g of soil yellow powder in a yield of 77.7percent.
Reference: [1] Patent: CN107253964, 2017, A, . Location in patent: Paragraph 0101; 0102; 0103; 0104
[2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 1, p. 245 - 256
  • 3
  • [ 4651-81-4 ]
  • [ 14080-50-3 ]
Reference: [1] Patent: US5654307, 1997, A,
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
  • 4
  • [ 4651-81-4 ]
  • [ 77287-34-4 ]
  • [ 55654-21-2 ]
  • [ 14080-50-3 ]
Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 30, p. 5261 - 5264
  • 5
  • [ 1189-71-5 ]
  • [ 4651-81-4 ]
  • [ 18740-38-0 ]
YieldReaction ConditionsOperation in experiment
78.8%
Stage #1: at -60 - 20℃;
Stage #2: at 75℃; for 1 h;
A 5 L reaction vial equipped with a mechanical stirrer, internal temperature probe, and a nitrogen bubbler was charged with methyl 2-aminothiophene-3 -carboxylate (95 g) and DCM (2.85 L) and cooled to -60 C chlorosulfonyl isocyanate (89.81 g) was added at a rate such that the internal temperature remained at -60 C to -55 C. After completion of addition the reaction was allowed to warm to ambient temperature. The reaction was monitored for complete consumption of starting material by LC/MS. The reaction mixture was concentrated to dryness in vacuo and the solid residue transferred back to the 5 1 reaction vial by water (1.8 L). This mixture was heated at 75 C for one hour, then cooled to 30 C. Next, 1OM aqueous NaOH (200 ML) was added and this mixture was heated at 85 C for 20 minutes before cooling to room temperature. The mixture was then acidified to pH=l by the addition of cone. HCl. The mixture was then stirred for 18 hours at ambient temperature with a ppt forming. This solid material was collected by vacuum filtration and the filter cake washed with water (3 x 30OmL). The solid material was then dried in an vacuum oven at 55 C for 24 hours to afford thieno[2,3-<f]pyrimidine-2,4(lH,3H)-dione as an off white solid (80.05 g, 78.8percent) 1U NMR (400 MHz, DMSO-J6) δ 7.083 (d, J= 5.6 Hz, IH), δ 7.124 (d, J= 5.6 Hz, IH) LCMS (ESI pos) m/e 169 (M+l)
Reference: [1] Patent: WO2008/73785, 2008, A2, . Location in patent: Page/Page column 169
[2] MedChemComm, 2014, vol. 5, # 12, p. 1821 - 1828
  • 6
  • [ 4651-81-4 ]
  • [ 57-13-6 ]
  • [ 18740-38-0 ]
YieldReaction ConditionsOperation in experiment
64% at 200℃; for 2 h; A mixture of methyl 2-aminothiophene-3-carboxylate 5a (20.0 g, 0.13 mol) and urea (60 g, 1.0 mol) was heated at 200 °C for 2 h. The reaction mixture was cooled and poured into a sodium hydroxide solution, and any insoluble material was removed by filtration. The filtrate was then acidified with 2 N HCl to give a white precipitate, which was collected by filtration, washed with water and dried on a funnel to provide the title compound 6a (13.7 g, yield 64percent). MS (ESI): C6H4N2O2S [M - H]- 167.1.
56.1% at 180℃; for 2 h; Urea (30 g, 0.5 mol) was added to methyl 2-aminothiophene-3-carboxylate (11, 10 g, 0.06 mol). Heated to 180 °C and stirred for 2 h. After cooling to 140 °C, reactant was dissolved with 1N sodium hydroxide solution. After filtration, 2N hydrochloric acid was added to the filtrate until pH 7. After filtration, the filtrate was refrigerated for 12 h and white solid appeared in the filtrate. The product was filtered off, washed with water and dry to afford 6.0 g thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (12). Yield: 56.1 percent,1H NMR (400 MHz, DMSO) δ 11.94 (s, 1H, CONH), 11.18 (s, 1H, CONH), 7.11 (d, J=16.0, 5.6 Hz, 2H,2 Ar–H) ESI-MS [M−H] m/z: 167.2.
56.1% at 180℃; for 2 h; Inert atmosphere Under nitrogen protection,2-Aminothiophene-3-carboxylic acidMethyl ester(10g) and urea (30g) were mixed evenly and mechanically stirredThe temperature was raised to 180 ° C and reacted for 2 h. The reaction was completed and cooled to below 100 ° C. The reaction was poured into 500 mL of 1 mol / LSodium hydroxide solution beaker, stir well, filter; with concentrated hydrochloric acid to adjust the filtrate to pH 6, precipitation of mud-like solid; filter, the filtrate frozen 12h after precipitation of solid,Suction filter yellowish product,Thieno [2,3-d] pyrimidine-2,4 (1H, 3H) -dione,Yield: 56.1percent.
Reference: [1] ChemMedChem, 2018,
[2] European Journal of Medicinal Chemistry, 2011, vol. 46, # 1, p. 71 - 76
[3] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 64 - 73
[4] Patent: CN106831812, 2017, A, . Location in patent: Paragraph 0088; 0089; 0090
[5] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1968, vol. 266, p. 128 - 130
[6] Patent: WO2006/79916, 2006, A1, . Location in patent: Page/Page column 92
[7] Patent: CN106167497, 2016, A, . Location in patent: Paragraph 0225; 0226; 0227
  • 7
  • [ 4651-81-4 ]
  • [ 18740-38-0 ]
YieldReaction ConditionsOperation in experiment
69% at 170℃; for 2 h; A solution of 10 g (0.064mol) methyl 2-aminothiophene-3-carboxylate was prepared 30 g (0.5 mol) of urea was placed in a 250 mL three-neck flaskAt 170 ° C for 2 hours. After the reaction was completed, the reaction mixture was poured into 1N sodium hydroxide solution, stirred and filtered. The filtrate was adjusted to pH 5 with 2N hydrochloric acid. A large amount of brown flocculent solid was precipitated, and the filtrate was refrigerated for 12h. A large amount of white solid precipitated, The filter cake was washed with 500 mL of water and dried at 50 ° C for 24 h to obtain 7.4 g of a white solid in 69percent yield.
Reference: [1] Patent: CN103980287, 2016, B, . Location in patent: Paragraph 0148; 0149; 0150
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
  • 8
  • [ 4651-81-4 ]
  • [ 917-61-3 ]
  • [ 18740-38-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4793 - 4805
  • 9
  • [ 4651-81-4 ]
  • [ 56844-12-3 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 4, p. 434 - 438
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
  • 10
  • [ 4651-81-4 ]
  • [ 63894-67-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
[2] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 64 - 73
[3] Patent: CN103980287, 2016, B,
[4] Patent: CN106831812, 2017, A,
  • 11
  • [ 4651-81-4 ]
  • [ 14080-59-2 ]
Reference: [1] Patent: CN104725398, 2017, B,
[2] Patent: CN107253964, 2017, A,
[3] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 1, p. 245 - 256
  • 12
  • [ 4651-81-4 ]
  • [ 18740-39-1 ]
Reference: [1] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1968, vol. 266, p. 128 - 130
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
[3] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 64 - 73
[4] Patent: CN103980287, 2016, B,
[5] Patent: CN106831812, 2017, A,
  • 13
  • [ 40018-26-6 ]
  • [ 105-34-0 ]
  • [ 4651-81-4 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine; N,N-dimethyl-formamide In methanol at 50℃; for 0.05 h; Sealed tube; Microwave irradiation; Inert atmosphere To two 20 mL microwave pressure vials was each added 1,4-dithiane-2,5-diol (2.0 g, 13.1mmol, 1.0 eq.) and MeOH (10.5 mL), and the vials were sealed. Through the septa was addedmethylcyanoacetate (2.32 mL, 26.3 mmol, 2.0 eq.), Et3N (1.28 mL, 9.20 mmol, 0.7 eq.), andDMF (3 drops), and the reactions were heated via microwave irradiation at 50 °C for 3 min. Atrt, the precipitates were combined and collected by filtration and washed with cold MeOH to provide 16as a white solid (3.88 g, 24.7 mmol, 94percent).
86% With triethylamine In methanol at 0 - 40℃; Thienopyrimidine Methyl 2-aminothiophene-3-carboxylate (1). l,4-Dithiane-2,5-diol (312.8 g, 2.05 mol) was mixed with MeOH (1000 mL), and methyl cyanoacetate (304.05 g, 3.06 mol) was added while stirring at 0 °C. Then NEt3 (72.55 g, 0.72 mol) was added drop wise over 2.5 h at 0 °C. The reaction temperature was slowly increased to 40 °C over 1 h. and kept stirring. After cooling to rt, the mixture was filtered and the liquid fraction was concentrated. The concentrated oil was extracted with boiling pet. ether (bp. 60-80 °C) (10χ750 mL). The combined organic fraction was concentrated which gave a solid crystalline product. After drying this gave 408.2 g (86percent) of 1, mp. 78 - 80 °C Rf (CHC13) = 0.33; 1H NMR (400 MHz, DMSO-d6) δ: 7.24 (s br, 2H, NH2), 6.81 (d, J= 5.8, 1H), 6.27 (d, J= 5.8, 1H), 3.69 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ: 164.8, 164.0, 124.9, 106.5, 103.7, 50.5. IR (neat, cm"1): 3421, 3319, 1655, 1316, 1273, 676; HRMS (EI, 70 eV, m/z): 157.0201 (calcd C6H7N02S, 157.0198, M+).
78% With triethylamine In methanol at 0 - 60℃; The synthesis was carried out as described by Hallas and Towns.18   1,4-Dithiane-2,5-diol (15.0 g, 99.0 mmol) was mixed with   MeOH (30 mL), and   methyl cyanoacetate (16.3 g, 164 mmol) was added while stirring. Then   NEt3 (5.98 g, 59.1 mmol) was added dropwise over 10 min at 0 °C. The reaction temperature was slowly increased to 60 °C over 1 h, and kept stirring for 1 h. After cooling to rt, the mixture was filtered and the liquid fraction was concentrated and allowed to crystallise at −18 °C for 18 h. The solid formed was isolated, washed with n-heptane (3×50 mL) and dried to yield 20.1 g (128 mmol, 78percent) of   1 as a yellowish solid, mp. 72–73 °C, (lit.15 77–78 °C); Rf (CHCl3)=0.33; 1H NMR (400 MHz, DMSO-d6) δ: 7.24 (s br, 2H, NH2), 6.81 (d, J=5.8, 1H), 6.27 (d, J=5.8, 1H), 3.69 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ: 164.8, 164.0, 124.9, 106.5, 103.7, 50.5; IR (neat, cm−1): 3421, 3319, 1655, 1316, 1273, 676; HRMS (EI, 70 eV, m/z): 157.0201 (calcd C6H7NO2S, 157.0198, M+). The 1H NMR spectrum from CDCl3 corresponded with that reported by Huang et al.39
64% With triethylamine In N,N-dimethyl-formamide at 0 - 20℃; for 3 h; Add in a 250 mL round bottom flask1,4-Dithio-2,5-diol (7.6 g, 50 mmol),Methyl cyanoacetate (9.9g, 100mmol) and 20mL DMF,The mixture was stirred at 0 °C.Triethylamine (3.6 g, 50 mmol) was gradually added dropwise to the reaction system.Stir at room temperature for 3 h.Quench with water, extract with methylene chloride, and remove the solvent on a rotary evaporator.Purification by column chromatography. White solid (11 g, 64percent) was obtained.
44% With triethylamine In methanol at 0 - 40℃; for 2.5 h; To a solution of methanol (35 g, 0.1 mol) in methyl cyanoacetate (10 g, 0.1 mol) and 1,4-dithiane-2,5-diol mL) was adjusted to 0°C and triethylamine (Et3N, 3.8 mL, 0.027 mol) was slowly added over 30 minutes and stirred at 40°C for 2 hours. The resulting solid was filtered and washed with diethyl ether to give compound 16 (7.014 g, 44percent) as a white solid.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 8, p. 1947 - 1953
[2] Patent: WO2015/959, 2015, A1, . Location in patent: Page/Page column 47
[3] Tetrahedron Letters, 2007, vol. 48, # 30, p. 5261 - 5264
[4] Tetrahedron, 2012, vol. 68, # 45, p. 9226 - 9233
[5] Patent: WO2005/63734, 2005, A2, . Location in patent: Page/Page column 60-61
[6] Patent: CN107573386, 2018, A, . Location in patent: Paragraph 0044-0047
[7] MedChemComm, 2015, vol. 6, # 2, p. 339 - 346
[8] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
[9] Chemical Biology and Drug Design, 2010, vol. 76, # 2, p. 116 - 129
[10] Patent: KR2017/92126, 2017, A, . Location in patent: Paragraph 0092-0096
[11] Patent: US5654307, 1997, A,
[12] Patent: US2007/99929, 2007, A1,
  • 14
  • [ 75-07-0 ]
  • [ 105-34-0 ]
  • [ 4651-81-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 9, p. 3620 - 3635
[2] European Journal of Medicinal Chemistry, 2019, vol. 161, p. 239 - 251
  • 15
  • [ 53982-98-2 ]
  • [ 4651-81-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 12, p. 2655 - 2660
  • 16
  • [ 4651-81-4 ]
  • [ 117516-97-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2016, vol. 14, # 27, p. 6398 - 6402
[2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 18, p. 4984 - 4995
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4651-81-4 ]

Esters

Chemical Structure| 31891-06-2

[ 31891-06-2 ]

Ethyl 2-aminothiophene-3-carboxylate

Similarity: 0.97

Chemical Structure| 59739-05-8

[ 59739-05-8 ]

tert-Butyl 2-aminothiophene-3-carboxylate

Similarity: 0.92

Chemical Structure| 43088-42-2

[ 43088-42-2 ]

Ethyl 2-amino-4-methylthiophene-3-carboxylate

Similarity: 0.90

Chemical Structure| 72965-16-3

[ 72965-16-3 ]

Ethyl 2-amino-4-isopropylthiophene-3-carboxylate

Similarity: 0.85

Chemical Structure| 55503-06-5

[ 55503-06-5 ]

Methyl 2-amino-5-chlorothiophene-3-carboxylate

Similarity: 0.82

Amines

Chemical Structure| 31891-06-2

[ 31891-06-2 ]

Ethyl 2-aminothiophene-3-carboxylate

Similarity: 0.97

Chemical Structure| 59739-05-8

[ 59739-05-8 ]

tert-Butyl 2-aminothiophene-3-carboxylate

Similarity: 0.92

Chemical Structure| 43088-42-2

[ 43088-42-2 ]

Ethyl 2-amino-4-methylthiophene-3-carboxylate

Similarity: 0.90

Chemical Structure| 72965-16-3

[ 72965-16-3 ]

Ethyl 2-amino-4-isopropylthiophene-3-carboxylate

Similarity: 0.85

Chemical Structure| 55503-06-5

[ 55503-06-5 ]

Methyl 2-amino-5-chlorothiophene-3-carboxylate

Similarity: 0.82